Clinical Trial Update: Adding Antiplatelet During Edoxaban Treatment in Stroke Patients With Non-valvular Atrial Fibrillation (ADD-ON)

View source ↗

Summary

A clinical trial update on adding an antiplatelet to edoxaban in patients with non-valvular atrial fibrillation after acute ischemic stroke to assess the safety…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Atrial Fibrillation
• Stroke

Drugs mentioned

• Savaysa (edoxaban)

Snippet

Sponsor: Asan Medical Center | Conditions: Acute Ischemic Stroke, Atrial Fibrillation | Status: ACTIVE_NOT_RECRUITING